Immune Escape Mechanisms in Colorectal Cancer Pathogenesis and Liver Metastasis

Over the past decade, growing evidence indicates that the tumor microenvironment (TME) contributes with genomic/epigenomic aberrations of malignant cells to enhance cancer cells survival, invasion, and dissemination. Many factors, produced or de novo synthesized by immune, stromal, or malignant cells, acting in a paracrine and autocrine fashion, remodel TME and the adaptive immune response culminating in metastasis. Taking into account the recent accomplishments in the field of immune oncology and using metastatic colorectal cancer (mCRC) as a model, we propose that the evasion of the immune surveillance and metastatic spread can be achieved through a number of mechanisms that include (a) intrinsic plasticity and adaptability of immune and malignant cells to paracrine and autocrine stimuli or genotoxic stresses; (b) alteration of positional schemes of myeloid-lineage cells, produced by factors controlling the balance between tumour-suppressing and tumour-promoting activities; (c) acquisition by cancer cells of aberrant immune-phenotypic traits (NT5E/CD73, CD68, and CD163) that enhance the interactions among TME components through the production of immune-suppressive mediators. These properties may represent the driving force of metastatic progression and thus clinically exploitable for cancer prevention and therapy. In this review we summarize results and suggest new hypotheses that favour the growing impact of tumor-infiltrating immune cells on tumour progression, metastasis, and therapy resistance.

• Publication year

  2014

• Venue

  Journal of Immunological Research

• Publication date

  2014-01-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1155/2014/686879PMID 24741617PMCID 3987978
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunogenic cell death.

  2015influential reference
• Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions

  2013cited by this paper
• Immunomonitoring and prognostic relevance of neutrophils in clinical trials.

  2013influential reference
• Right-sided rhabdoid colorectal tumors might be related to the Serrated Pathway

  2013cited by this paper
• Macrophage plasticity and polarization in tissue repair and remodelling

  2013cited by this paper
• Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.

  2013cited by this paper
• A colorectal cancer classification system that associates cellular phenotype and responses to therapy

  2013cited by this paper
• Ensemble of Gene Signatures Identifies Novel Biomarkers in Colorectal Cancer Activated through PPARγ and TNFα Signaling

  2013cited by this paper
• Role of macrophage targeting in the antitumor activity of trabectedin.

  2013cited by this paper
• On the cytokines produced by human neutrophils in tumors.

  2013cited by this paper
• The metastasis-promoting roles of tumor-associated immune cells

  2013cited by this paper
• Macrophage regulation of tumor responses to anticancer therapies.

  2013cited by this paper
• Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?

  2013cited by this paper
• The metastasis-promoting roles of tumor-associated immune cells

  2013cited by this paper
• The emerging "hallmarks" of metabolic reprogramming and immune evasion: distinct or linked?

  2013cited by this paper
• Genetic and Epigenetic Events Generate Multiple Pathways in Colorectal Cancer Progression

  2012cited by this paper
• Endothelial cells provide an instructive niche for the differentiation and functional polarization of M2-like macrophages.

  2012cited by this paper
• Colorectal cancer: a tale of two sides or a continuum?

  2012cited by this paper
• Macrophage plasticity and polarization: in vivo veritas.

  2012cited by this paper
• CD73-Generated Adenosine: Orchestrating the Tumor-Stroma Interplay to Promote Cancer Growth

  2012cited by this paper
• The double-edge sword effect of anti-CD73 cancer therapy

  2012cited by this paper
• Coordinated regulation of myeloid cells by tumours

  2012cited by this paper
• Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth

  2012cited by this paper
• Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen.

  2012cited by this paper
• Tumor‐promoting macrophages induce the expression of the macrophage‐specific receptor CD163 in malignant cells

  2012cited by this paper
• Premetastatic niche: ready for new therapeutic interventions?

  2012cited by this paper
• Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance.

  2012cited by this paper
• I and J

  2012cited by this paper
• The Distribution of Macrophages with a M1 or M2 Phenotype in Relation to Prognosis and the Molecular Characteristics of Colorectal Cancer

  2012cited by this paper
• Molecular pathology of colorectal carcinoma. A systematic review centred on the new role of the pathologist.

  2012cited by this paper
• Comprehensive molecular characterization of human colon and rectal cancer

  2012cited by this paper
• Accessories to the crime: functions of cells recruited to the tumor microenvironment.

  2012cited by this paper
• Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils

  2011cited by this paper
• Unravelling the complexity of metastasis — molecular understanding and targeted therapies

  2011cited by this paper
• Macrophage regulation of tumor angiogenesis: implications for cancer therapy.

  2011cited by this paper
• Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer

  2011cited by this paper
• The interplay between macrophages and angiogenesis in development, tissue injury and regeneration.

  2011cited by this paper
• The Inflammatory Microenvironment in Colorectal Neoplasia

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Activation of Tumor-Promoting Type 2 Macrophages by EGFR-Targeting Antibody Cetuximab

  2011cited by this paper
• Activated macrophages induce metastatic behavior of colon cancer cells.

  2010cited by this paper
• Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients

  2010cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer

  2010cited by this paper
• Immune evasion of microsatellite unstable colorectal cancers

  2010cited by this paper
• Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects

  2010cited by this paper
• Macrophage diversity enhances tumor progression and metastasis.

  2010cited by this paper
• Risk factors: CD8+:FOXP3+ cell ratio is a novel survival marker for colorectal cancer

  2010cited by this paper
• Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer.

  2010cited by this paper
• CD73: a novel target for cancer immunotherapy.

  2010cited by this paper
• Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation.

  2010cited by this paper
• Vascular Endothelial Growth Factor

  2009cited by this paper
• Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype

  2009cited by this paper
• Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time

  2009cited by this paper
• Microenvironmental regulation of metastasis

  2009cited by this paper
• Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.

  2009cited by this paper
• In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.

  2009cited by this paper
• The Tumor Microenvironment: The Making of a Paradigm

  2009cited by this paper
• CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.

  2009cited by this paper
• The role of inflammation in the pathogenesis of colorectal cancer

  2009cited by this paper
• Evolving treatment of advanced colon cancer.

  2009cited by this paper
• Myeloid-derived suppressor cells as regulators of the immune system

  2009cited by this paper
• Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation.

  2009cited by this paper
• Immune cells as mediators of solid tumor metastasis

  2008cited by this paper
• Cancer-related inflammation

  2008cited by this paper
• High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability

  2008cited by this paper
• VEGF-targeted therapy: mechanisms of anti-tumour activity

  2008influential reference
• Detection and Functional Analysis of Tumor Infiltrating T-Lymphocytes (TIL) in Liver Metastases from Colorectal Cancer

  2008cited by this paper
• Tumor-Infiltrating Lymphocytes and Perforation in Colon Cancer Predict Positive Response to 5-Fluorouracil Chemotherapy

  2008cited by this paper
• Colon Cancer: It's CIN or CIMP

  2008cited by this paper
• Plasticity of Macrophage Function during Tumor Progression: Regulation by Distinct Molecular Mechanisms1

  2008cited by this paper
• Migratory neighbors and distant invaders: tumor-associated niche cells.

  2008cited by this paper
• Detection and Functional Analysis of Tumor Infiltrating T-Lymphocytes (TIL) in Liver Metastases from Colorectal Cancer

  2008cited by this paper
• The essential role of the in situ immune reaction in human colorectal cancer

  2008cited by this paper
• The premetastatic niche

  2008cited by this paper
• Cancer: Inflaming metastasis

  2008cited by this paper
• Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer.

  2007cited by this paper
• High Macrophage Infiltration along the Tumor Front Correlates with Improved Survival in Colon Cancer

  2007cited by this paper
• Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer.

  2007cited by this paper
• Drug resistance and the solid tumor microenvironment.

  2007cited by this paper
• Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy.

  2006cited by this paper
• T Regulatory and Primed Uncommitted CD4 T Cells Express CD73, Which Suppresses Effector CD4 T Cells by Converting 5′-Adenosine Monophosphate to Adenosine1

  2006cited by this paper
• Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach

  2006cited by this paper
• Preparing the "soil": the premetastatic niche.

  2006cited by this paper
• Influence of cultivation temperature on the ligninolytic activity of selected fungal strains

  2006cited by this paper
• Role of tumor-associated macrophages in tumor progression and invasion

  2006cited by this paper
• Macrophages: obligate partners for tumor cell migration, invasion, and metastasis.

  2006cited by this paper
• Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

  2006cited by this paper
• Molecular mechanisms of hepatic metastasis in colorectal cancer

  2005cited by this paper
• Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases

  2005cited by this paper
• Effector memory T cells, early metastasis, and survival in colorectal cancer.

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Γ and B

  2004cited by this paper
• Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability.

  2004cited by this paper
• Tumour-educated macrophages promote tumour progression and metastasis

  2004cited by this paper
• Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.

  2004cited by this paper
• Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism.

  2004cited by this paper
• Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

  2004cited by this paper
• Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma

  2003cited by this paper
• VEGF and the quest for tumour angiogenesis factors

  2002cited by this paper

• Unraveling the Potential of Photochemical Nanoplatforms in Tumor Microenvironments: Therapeutic Strategies for Gastrointestinal Malignancies

  2026cites this paper
• IER3 Promotes Malignant Progression of Colorectal Cancer Through the NF‐κB Pathway

  2026cites this paper
• Machine perfusion and single-cell spatial transcriptome mapping identifies novel immune escape mechanisms in colorectal cancer liver metastasis

  2025cites this paper
• Colorectal Cancer Cell's Weapon: RNF32 Engages SPP1+ Macrophages to Foster Liver Metastasis, Targeted by Indole‐3‐Acetic Acid

  2025cites this paper
• Modulation of the tumor microenvironment by the ubiquitin–proteasome system in colorectal cancer

  2025cites this paper
• M1-like tumor-associated macrophages promote colorectal cancer progression through feedback activation of the IL1β/NF-κB signaling activity.

  2025cites this paper
• Colorectal clear cell carcinoma: a literature review

  2025cites this paper
• Do the expressions of HLA-G and killer cell immunoglobulin-like receptors change in colorectal cancer?

  2025cites this paper
• From inflammation to carcinogenesis: Distinct pathways and clinical implications of IBD-associated colorectal cancer compared with sporadic CRC.

  2025cites this paper
• A Pan-Cancer Analysis of Lesion-Level Treatment Response to Extend the ‘Seed and Soil’ Paradigm

  2025cites this paper
• Durvalumab and tremelimumab plus local partial tumour ablation (radiofrequency ablation or stereotactic radiotherapy) in patients with unresectable liver metastases from metastatic colorectal cancer: results of the EORTC-1560-GITCG multicentre, single-arm phase II study (ILOC)

  2025cites this paper
• MiR-30d-5p Modulates Glucose and Lipid Metabolism by Targeting CD73 through the AMPK Pathway

  2025cites this paper
• Examining the Role of Virulence Proteins From Pathogenic Anaerobes in the Initiation of Colorectal Cancer

  2025cites this paper
• Functions and mechanisms of lncRNAs in immune escape and their application in immunotherapy for colorectal cancer

  2025cites this paper
• The tumor microenvironment and dendritic cells: Developers of pioneering strategies in colorectal cancer immunotherapy?

  2025cites this paper
• Genomic and micro-environmental insights into drug resistance in colorectal cancer liver metastases

  2025influential citation
• Effect of Gut Microbiota Alteration on Colorectal Cancer Progression in an In Vivo Model: Histopathological and Immunological Evaluation

  2025cites this paper
• The current role of dendritic cells in the progression and treatment of colorectal cancer

  2024cites this paper
• The possible anti-tumor effects of regulatory T cells plasticity / IL-35 in the tumor microenvironment of the major three cancer types.

  2024cites this paper
• Yanghe decoction inhibits inflammation-induced lung metastasis of colorectal cancer.

  2024cites this paper
• Effect of colorectal cancer stem cells on the development and metastasis of colorectal cancer

  2024cites this paper
• Blockade of CD73 potentiates radiotherapy antitumor immunity and abscopal effects via STING pathway

  2024cites this paper
• Centrosomal Protein 55 (CEP55) Drives Immune Exclusion and Resistance to Immune Checkpoint Inhibitors in Colorectal Cancer

  2024cites this paper
• Establishment and verification of prognostic model and ceRNA network analysis for colorectal cancer liver metastasis

  2023cites this paper
• Predictive modeling algorithms for liver metastasis in colorectal cancer: A systematic review of the current literature

  2023cites this paper
• Fragment-sequencing unveils local tissue microenvironments at single-cell resolution

  2023cites this paper
• The Function, Underlying Mechanism and Clinical Potential of Exosomes in Colorectal Cancer.

  2023cites this paper
• B7-H3 at the crossroads between tumor plasticity and colorectal cancer progression: a potential target for therapeutic intervention

  2023cites this paper
• FHIP1A-DT is a potential novel diagnostic, prognostic, and therapeutic biomarker of colorectal cancer: A pan-cancer analysis.

  2023cites this paper
• Single-cell transcriptome analysis reveals T population heterogeneity and functions in tumor microenvironment of colorectal cancer metastases

  2023cites this paper
• Differential profile of protumor immunological factors between the tumor site and the tumor-free site - predictive potential of IL-8 and COX2 for colorectal cancer and metastasis.

  2023cites this paper
• Upregulation of APOC1 Promotes Colorectal Cancer Progression and Serves as a Potential Therapeutic Target Based on Bioinformatics Analysis

  2023cites this paper
• Functional and Therapeutic Significance of Tumor-Associated Macrophages in Colorectal Cancer

  2022cites this paper
• LncRNA PROX1 antisense RNA 1 promotes PD-L1-mediated proliferation, metastasis, and immune escape in colorectal cancer by interacting with miR-520d

  2022cites this paper
• TRIM27 is an adverse prognostic biomarker and associated with immune and molecular profiles in right-sided colon cancer.

  2022cites this paper
• How the Tumor Micromilieu Modulates the Recruitment and Activation of Colorectal Cancer-Infiltrating Lymphocytes

  2022cites this paper
• Intracellular and extracellular factors of colorectal cancer liver metastasis: a pivotal perplex to be fully elucidated

  2022cites this paper
• Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs

  2022cites this paper
• Associating resistance to immune checkpoint inhibitors with immunological escape in colorectal cancer

  2022influential citation
• Role of the Ghrelin System in Colitis and Hepatitis as Risk Factors for Inflammatory-Related Cancers

  2022influential citation
• Application of RNA processing factors for predicting clinical outcomes in colon cancer

  2022cites this paper
• Role of tumour derived exosomes in manuring the metastatic niche in patients with lung cancer liver metastasis: Beyond seed soil hypothesis

  2022cites this paper
• Comprehensive analysis to identify the RP11–478C19.2/ E2F7 axis as a novel biomarker for treatment decisions in clear cell renal cell carcinoma

  2022cites this paper
• Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells

  2022cites this paper
• HBV Infection Status Indicates Different Risks of Synchronous and Metachronous Liver Metastasis in Colorectal Cancer: A Retrospective Study of 3132 Patients with a 5-Year Follow-Up

  2022cites this paper
• Histone Methyltransferase SETDB1 Promotes Immune Evasion in Colorectal Cancer via FOSB-Mediated Downregulation of MicroRNA-22 through BATF3/PD-L1 Pathway

  2022cites this paper
• The Role of Small Extracellular Vesicles in the Progression of Colorectal Cancer and Its Clinical Applications

  2022cites this paper
• Lactoferrin: A Nutraceutical with Activity against Colorectal Cancer

  2022cites this paper
• Chitosan nanoparticles as a promising candidate for liver injury induced by 2-nitropropane: Implications of P53, iNOS, VEGF, PCNA, and CD68 pathways

  2021cites this paper
• Sex, Type of Surgery, and Surgical Site Infections Are Associated with Perioperative Cortisol in Colorectal Cancer Patients

  2021cites this paper
• Risk of Second Primary Malignancies Based on the Histological Subtypes of Colorectal Cancer

  2021cites this paper
• Primary tumor immune score fails to predict the prognosis of colorectal cancer liver metastases after hepatectomy in Chinese populations

  2021cites this paper
• Molecular Subtypes and CD4+ Memory T Cell-Based Signature Associated With Clinical Outcomes in Gastric Cancer

  2021cites this paper
• Tracking the Antibody Immunome in Sporadic Colorectal Cancer by Using Antigen Self-Assembled Protein Arrays

  2021cites this paper
• Irinotecan eluting beads-transarterial chemoembolization using Callispheres® microspheres is an effective and safe approach in treating unresectable colorectal cancer liver metastases

  2021cites this paper
• Interleukin-1 receptor antagonist inhibits matastatic potential by down-regulating CXCL12/CXCR4 signaling axis in colorectal cancer

  2021cites this paper
• RBP-J promotes cell growth and metastasis through regulating miR-182-5p-mediated Tiam1/Rac1/p38 MAPK axis in colorectal cancer.

  2021cites this paper
• Non-intubated video-assisted pulmonary metastasectomy: a narrative literature review

  2021cites this paper
• Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patients

  2021cites this paper
• Elucidating tumor immunosurveillance and immunoediting: a comprehensive review

  2021cites this paper
• HBV Infection Statuses Indicate Different Risks of Synchronous and Metastasis Liver Metastasis in Colorectal Cancer

  2021cites this paper
• Tumor stemness and immune infiltration synergistically predict response of radiotherapy or immunotherapy and relapse in lung adenocarcinoma

  2021cites this paper
• IEO model: A novel concept describing the complete metastatic process in the liver microenvironment.

  2020cites this paper
• Noninvasive urinary protein signatures associated with colorectal cancer diagnosis and metastasis

  2020cites this paper
• Downregulation of Interferon- g Receptor Expression Endows Resistance to Anti – Programmed Death Protein 1 Therapy in Colorectal Cancer s

  2020cites this paper
• Down-regulation of the IFN-γ receptor expression endows resistance to anti-PD-1 therapy in colorectal cancer

  2020cites this paper
• Downregulation of Interferon-γ Receptor Expression Endows Resistance to Anti–Programmed Death Protein 1 Therapy in Colorectal Cancer

  2020cites this paper
• Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis

  2020influential citation
• Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis

  2020cites this paper
• Toll-like receptor immune modulatory role in personalized management of colorectal cancer, review of literature

  2020cites this paper
• Noninvasive urinary protein signatures associated with colorectal cancer diagnosis 1 and metastasis

  2020cites this paper
• HBV infection may reduce the risk of metachronous liver metastasis in postoperative pathological stage 2 colorectal cancer

  2020cites this paper
• Quercetin Suppresses AOM/DSS-Induced Colon Carcinogenesis through Its Anti-Inflammation Effects in Mice

  2020cites this paper
• Clinical assessment and identification of immuno-oncology markers concerning the 19-gene based risk classifier in stage IV colorectal cancer

  2019cites this paper
• Curcumin Inhibits the Proliferation, Migration, Invasion, and Apoptosis of Diffuse Large B-Cell Lymphoma Cell Line by Regulating MiR-21/VHL Axis

  2019cites this paper
• Therapeutic Value of CD73 as a Biomarker in Human Cancer

  2019cites this paper
• Critical considerations for targeting colorectal liver metastases with nanotechnology

  2019cites this paper
• Recombinant Virus-like Particles Presenting IL-33 Successfully Modify the Tumor Microenvironment and Facilitate Antitumor Immunity in a Model of Breast Cancer.

  2019cites this paper
• Morphology and Molecular Features of Rare Colorectal Carcinoma Histotypes

  2019cites this paper
• Long-Term Results and Prognostic Significance of Non-ANATOMIC Liver Resection for Colorectal Liver Metastasis: Single Center Experience

  2019cites this paper
• Roles of exosomes in liver metastases: Novel diagnosis and treatment choices

  2019influential citation
• Systemic and local inflammation in colorectal cancer.

  2019cites this paper
• Novel immune–risk score of gastric cancer: A molecular prediction model combining the value of immune–risk status and chemosensitivity

  2019cites this paper
• Genética del carcinoma colorrectal con agregación familiar, en una muestra de la Región Andina colombiana

  2019cites this paper
• CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients.

  2018cites this paper
• Combination of capecitabine and ludartin inhibits colon cancer growth in mice

  2018cites this paper
• The role of exosomes on colorectal cancer: A review

  2018cites this paper
• Inhibition of colorectal cancer liver metastasis in BALB/c mice following intratumoral injection of oncolytic herpes simplex virus type 2 for the induction of specific antitumor immunity

  2018cites this paper
• Prognostic significance of CD68, CD163 and Folate receptor-β positive macrophages in hepatocellular carcinoma.

  2018cites this paper
• CD 38 + M-MDSC expansion characterizes a subset of advanced colorectal cancer patients

  2018cites this paper
• Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures

  2017cites this paper
• Interleukin-35 expression is associated with colon cancer progression

  2017cites this paper
• Interleukin-37 mediates the antitumor activity in colon cancer through β-catenin suppression

  2017cites this paper
• Characterization of the Pro-Inflammatory Cytokine IL-1[beta] on Butyrate Metabolism in Colorectal Cancer Cells

  2017cites this paper
• Characteristics of circulating tumor cells in organ metastases, prognosis, and T lymphocyte mediated immune response

  2017cites this paper
• Anti and pro-inflammatory cytokine gene expression in patients suffering from cancer bladder associated with chronic schistosomiasis haematobium

  2017cites this paper
• P2Y2 Receptor Functions in Cancer: A Perspective in the Context of Colorectal Cancer.

  2017cites this paper
• α7 nicotinic acetylcholine receptor in tumor-associated macrophages inhibits colorectal cancer metastasis through the JAK2/STAT3 signaling pathway

  2017cites this paper
• Heterogeneity of colon cancer: from bench to bedside

  2017cites this paper
• Colorectal cancer cells suppress CD4+ T cells immunity through canonical Wnt signaling

  2017cites this paper